BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 25932897)

  • 1. Selectivity optimization of substituted 1,2,3-triazoles as α7 nicotinic acetylcholine receptor agonists.
    Arunrungvichian K; Fokin VV; Vajragupta O; Taylor P
    ACS Chem Neurosci; 2015 Aug; 6(8):1317-30. PubMed ID: 25932897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of selective agonists for the α7 nicotinic acetylcholine receptor with in situ click-chemistry on acetylcholine-binding protein templates.
    Yamauchi JG; Gomez K; Grimster N; Dufouil M; Nemecz A; Fotsing JR; Ho KY; Talley TT; Sharpless KB; Fokin VV; Taylor P
    Mol Pharmacol; 2012 Oct; 82(4):687-99. PubMed ID: 22784805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New quinoline derivatives as nicotinic receptor modulators.
    Manetti D; Bellucci C; Dei S; Teodori E; Varani K; Spirova E; Kudryavtsev D; Shelukhina I; Tsetlin V; Romanelli MN
    Eur J Med Chem; 2016 Mar; 110():246-58. PubMed ID: 26840365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cognitive improvements in a mouse model with substituted 1,2,3-triazole agonists for nicotinic acetylcholine receptors.
    Arunrungvichian K; Boonyarat C; Fokin VV; Taylor P; Vajragupta O
    ACS Chem Neurosci; 2015 Aug; 6(8):1331-40. PubMed ID: 25978789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design of α7 nicotinic acetylcholine receptor ligands using the (het)Aryl-1,2,3-triazole core: Synthesis, in vitro evaluation and SAR studies.
    Ouach A; Pin F; Bertrand E; Vercouillie J; Gulhan Z; Mothes C; Deloye JB; Guilloteau D; Suzenet F; Chalon S; Routier S
    Eur J Med Chem; 2016 Jan; 107():153-64. PubMed ID: 26580980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Benzylpiperidine Derivatives as α7 Nicotinic Receptor Antagonists.
    Criado M; Mulet J; Sala F; Sala S; Colmena I; Gandía L; Bautista-Aguilera OM; Samadi A; Chioua M; Marco-Contelles J
    ACS Chem Neurosci; 2016 Aug; 7(8):1157-65. PubMed ID: 27254782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dissection of tropisetron, an alpha7 nicotinic acetylcholine receptor-selective partial agonist.
    Papke RL; Schiff HC; Jack BA; Horenstein NA
    Neurosci Lett; 2005 Apr; 378(3):140-4. PubMed ID: 15781147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structurally similar allosteric modulators of α7 nicotinic acetylcholine receptors exhibit five distinct pharmacological effects.
    Gill-Thind JK; Dhankher P; D'Oyley JM; Sheppard TD; Millar NS
    J Biol Chem; 2015 Feb; 290(6):3552-62. PubMed ID: 25516597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The novel α7β2-nicotinic acetylcholine receptor subtype is expressed in mouse and human basal forebrain: biochemical and pharmacological characterization.
    Moretti M; Zoli M; George AA; Lukas RJ; Pistillo F; Maskos U; Whiteaker P; Gotti C
    Mol Pharmacol; 2014 Sep; 86(3):306-17. PubMed ID: 25002271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Pharmacological Characterization, and Structure-Activity Relationships of Noncanonical Selective Agonists for α7 nAChRs.
    Camacho-Hernandez GA; Stokes C; Duggan BM; Kaczanowska K; Brandao-Araiza S; Doan L; Papke RL; Taylor P
    J Med Chem; 2019 Nov; 62(22):10376-10390. PubMed ID: 31675224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New Rigid Nicotine Analogues, Carrying a Norbornane Moiety, Are Potent Agonists of α7 and α3* Nicotinic Receptors.
    Manetti D; Garifulina A; Bartolucci G; Bazzicalupi C; Bellucci C; Chiaramonte N; Dei S; Di Cesare Mannelli L; Ghelardini C; Gratteri P; Spirova E; Shelukhina I; Teodori E; Varani K; Tsetlin V; Romanelli MN
    J Med Chem; 2019 Feb; 62(4):1887-1901. PubMed ID: 30681854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification by virtual screening and functional characterisation of novel positive and negative allosteric modulators of the α7 nicotinic acetylcholine receptor.
    Smelt CLC; Sanders VR; Newcombe J; Burt RP; Sheppard TD; Topf M; Millar NS
    Neuropharmacology; 2018 Sep; 139():194-204. PubMed ID: 30009834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel 2-(substituted benzyl)quinuclidines inhibit human α7 and α4β2 nicotinic receptors by different mechanisms.
    Arias HR; López JJ; Feuerbach D; Fierro A; Ortells MO; Pérez EG
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2420-30. PubMed ID: 23954208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo neuronal nicotinic receptor properties of (+)- and (-)-pyrido[3,4]homotropane [(+)- and (-)-PHT]: (+)-PHT is a potent and selective full agonist at α6β2 containing neuronal nicotinic acetylcholine receptors.
    Carroll FI; Navarro HA; Mascarella SW; Castro AH; Luetje CW; Wageman CR; Marks MJ; Jackson A; Damaj MI
    ACS Chem Neurosci; 2015 Jun; 6(6):920-6. PubMed ID: 25891987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substituted 2-Aminopyrimidines Selective for α7-Nicotinic Acetylcholine Receptor Activation and Association with Acetylcholine Binding Proteins.
    Kaczanowska K; Camacho Hernandez GA; Bendiks L; Kohs L; Cornejo-Bravo JM; Harel M; Finn MG; Taylor P
    J Am Chem Soc; 2017 Mar; 139(10):3676-3684. PubMed ID: 28221788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbamoylcholine homologs: novel and potent agonists at neuronal nicotinic acetylcholine receptors.
    Jensen AA; Mikkelsen I; Frølund B; Bräuner-Osborne H; Falch E; Krogsgaard-Larsen P
    Mol Pharmacol; 2003 Oct; 64(4):865-75. PubMed ID: 14500743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α7 and β2 Nicotinic Acetylcholine Receptor Subunits Form Heteromeric Receptor Complexes that Are Expressed in the Human Cortex and Display Distinct Pharmacological Properties.
    Thomsen MS; Zwart R; Ursu D; Jensen MM; Pinborg LH; Gilmour G; Wu J; Sher E; Mikkelsen JD
    PLoS One; 2015; 10(6):e0130572. PubMed ID: 26086615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural differences determine the relative selectivity of nicotinic compounds for native alpha 4 beta 2*-, alpha 6 beta 2*-, alpha 3 beta 4*- and alpha 7-nicotine acetylcholine receptors.
    Grady SR; Drenan RM; Breining SR; Yohannes D; Wageman CR; Fedorov NB; McKinney S; Whiteaker P; Bencherif M; Lester HA; Marks MJ
    Neuropharmacology; 2010 Jun; 58(7):1054-66. PubMed ID: 20114055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and structural and pharmacological characterization of α-elapitoxin-Dpp2d, an amidated three finger toxin from black mamba venom.
    Wang CI; Reeks T; Vetter I; Vergara I; Kovtun O; Lewis RJ; Alewood PF; Durek T
    Biochemistry; 2014 Jun; 53(23):3758-66. PubMed ID: 24867092
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies.
    Peng W; Ding F
    Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.